Im, Jisu http://orcid.org/0000-0003-0972-3048
Hillenaar, Tamara http://orcid.org/0000-0003-0672-2947
Yeoh, Hui Ying
Sahasrabudhe, Priyanka http://orcid.org/0000-0002-8666-0055
Mijnders, Marjolein http://orcid.org/0000-0002-2962-0479
van Willigen, Marcel http://orcid.org/0000-0003-3510-7564
Hagos, Azib
de Mattos, Eduardo http://orcid.org/0000-0001-9395-2059
van der Sluijs, Peter http://orcid.org/0000-0002-4485-3342
Braakman, Ineke http://orcid.org/0000-0003-1592-4364
Funding for this research was provided by:
Cystic Fibrosis Foundation Therapeutics (BRAAKM14XX0, BRAAKM18G0)
Nederlandse Cystic Fibrosis Stichting (HIT CF, HIT CF 2.0)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (022.004.019, 731.016.403)
Horizon 2020 Framework Programme (H2020-MSCA-IF-2017 Mem-Chaps)
EMBO (ALTF 1085-2017)
ZonMw (40-00812-98-14103)
Stichting Zeldzame Ziekten Fonds (Helpende handen om CF te genezen)
Cystic Fibrosis Trust (SRC 021)
Article History
Received: 20 July 2022
Revised: 1 November 2022
Accepted: 28 November 2022
First Online: 7 January 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.